Jacqueline Whang‐Peng

18.4k total citations · 5 hit papers
319 papers, 15.0k citations indexed

About

Jacqueline Whang‐Peng is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jacqueline Whang‐Peng has authored 319 papers receiving a total of 15.0k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Oncology, 95 papers in Molecular Biology and 76 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jacqueline Whang‐Peng's work include Lung Cancer Treatments and Mutations (44 papers), Lung Cancer Research Studies (41 papers) and Chronic Lymphocytic Leukemia Research (24 papers). Jacqueline Whang‐Peng is often cited by papers focused on Lung Cancer Treatments and Mutations (44 papers), Lung Cancer Research Studies (41 papers) and Chronic Lymphocytic Leukemia Research (24 papers). Jacqueline Whang‐Peng collaborates with scholars based in Taiwan, United States and France. Jacqueline Whang‐Peng's co-authors include Tor Knutsen, Turid Knutsen, Adi F. Gazdar, John D. Minna, Frederic J. Kaye, J. William Harbour, Timothy J. Triche, Yuh-Min Chen, George P. Canellos and Robert F. Ozols and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jacqueline Whang‐Peng

314 papers receiving 14.3k citations

Hit Papers

Abnormalities in Structure and Expression of the Human Re... 1983 2026 1997 2011 1988 2004 2006 1983 1987 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Abnormalities in Structure and Expression of the Human Retinoblastoma Gene in SCLC
    1988 752 citations Jacqueline Whang‐Peng et al. profile →
  2. In vitro Hepatic Differentiation of Human Mesenchymal Stem Cells
    2004 725 citations Jacqueline Whang‐Peng et al. profile →
  3. Nodal dissection for patients with gastric cancer: a randomised controlled trial
    2006 482 citations Jacqueline Whang‐Peng et al. profile →
  4. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.
    1983 470 citations Jacqueline Whang‐Peng et al. profile →
  5. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    1987 440 citations Jacqueline Whang‐Peng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacqueline Whang‐Peng Taiwan 63 5.6k 5.0k 3.1k 1.8k 1.8k 319 15.0k
Massimo Aglietta Italy 58 3.6k 0.6× 7.1k 1.4× 2.8k 0.9× 1.3k 0.7× 1.9k 1.1× 397 14.5k
James F. Holland United States 59 4.3k 0.8× 5.6k 1.1× 2.1k 0.7× 1.4k 0.8× 2.1k 1.2× 400 15.6k
Joseph R. Bertino United States 75 10.2k 1.8× 8.6k 1.7× 2.4k 0.8× 1.3k 0.7× 2.5k 1.4× 471 23.2k
Mitsune Tanimoto Japan 58 4.2k 0.7× 5.2k 1.0× 4.5k 1.4× 1.2k 0.6× 1.2k 0.7× 525 13.7k
Christian Peschel Germany 69 5.8k 1.0× 5.2k 1.0× 3.1k 1.0× 2.7k 1.5× 1.6k 0.9× 345 16.8k
Charles Dumontet France 69 9.2k 1.6× 8.6k 1.7× 2.2k 0.7× 1.8k 1.0× 1.9k 1.1× 377 20.7k
Joel S. Greenberger United States 68 7.7k 1.4× 3.1k 0.6× 3.2k 1.0× 2.8k 1.5× 1.7k 1.0× 447 18.6k
Minna Tanner United Kingdom 70 7.1k 1.3× 4.6k 0.9× 2.8k 0.9× 899 0.5× 2.5k 1.4× 243 15.3k
Maurizio D’Incalci Italy 69 8.4k 1.5× 6.5k 1.3× 3.2k 1.0× 752 0.4× 3.2k 1.8× 531 17.4k
Susan M. Blaney United States 63 5.0k 0.9× 3.3k 0.7× 3.0k 0.9× 2.5k 1.4× 1.2k 0.7× 267 11.4k

Countries citing papers authored by Jacqueline Whang‐Peng

Since Specialization
Citations

This map shows the geographic impact of Jacqueline Whang‐Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacqueline Whang‐Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacqueline Whang‐Peng more than expected).

Fields of papers citing papers by Jacqueline Whang‐Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacqueline Whang‐Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacqueline Whang‐Peng. The network helps show where Jacqueline Whang‐Peng may publish in the future.

Co-authorship network of co-authors of Jacqueline Whang‐Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jacqueline Whang‐Peng. A scholar is included among the top collaborators of Jacqueline Whang‐Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacqueline Whang‐Peng. Jacqueline Whang‐Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Yen‐Kuang, Yen‐Lin Liu, Yun Yen, et al.. (2024). The Effect of Oncology Nurse Navigation on Mental Health in Patients with Cancer in Taiwan: A Randomized Controlled Clinical Trial. Current Oncology. 31(7). 4105–4122. 1 indexed citations
2.
Luca, Roberto De, Chi‐Hung Huang, Yu‐Chen S. H. Yang, et al.. (2022). Heteronemin and tetrac derivatives suppress non-small cell lung cancer growth via ERK1/2 inhibition. Food and Chemical Toxicology. 161. 112850–112850. 10 indexed citations
3.
Cheng, Tsai-Mu, Roberto De Luca, Jens Z. Pedersen, et al.. (2021). Nano-Strategies Targeting the Integrin αvβ3 Network for Cancer Therapy. Cells. 10(7). 1684–1684. 52 indexed citations
4.
Chen, Yi‐Ru, Yu‐Tang Chin, Ya-Jung Shih, et al.. (2019). Thyroid hormone-induced expression of inflammatory cytokines interfere with resveratrol-induced anti-proliferation of oral cancer cells. Food and Chemical Toxicology. 132. 110693–110693. 28 indexed citations
5.
Lin, Hung‐Yun, Yih Ho, Yu‐Tang Chin, et al.. (2018). Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway. Marine Drugs. 16(12). 489–489. 13 indexed citations
6.
Luo, Yung‐Hung, Yu‐Chin Lee, Jacqueline Whang‐Peng, & Yuh‐Min Chen. (2015). Critical Appraisal of Gefitinib in the Treatment of Non-Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 2 indexed citations
7.
Whang‐Peng, Jacqueline, Leroy F. Liu, Shin Nieh, et al.. (2012). A novel synthetic bipartite carrier protein for developing glycotope-based vaccines. Vaccine. 30(52). 7573–7581. 9 indexed citations
8.
Chen, Li‐Tzong, Miin-Fu Chen, Po‐Huang Lee, et al.. (2011). Long-Term Results of a Randomized, Observation-Controlled, Phase III Trial of Adjuvant Interferon Alfa-2b in Hepatocellular Carcinoma After Curative Resection. Annals of Surgery. 255(1). 8–17. 110 indexed citations
9.
Ch’ang, Hui-Ju, Yulin Lin, Hsiu-Po Wang, et al.. (2011). Induction Chemotherapy With Gemcitabine, Oxaliplatin, and 5-Fluorouracil/Leucovorin Followed by Concomitant Chemoradiotherapy in Patients With Locally Advanced Pancreatic Cancer: A Taiwan Cooperative Oncology Group Phase II Study. International Journal of Radiation Oncology*Biology*Physics. 81(5). e749–e757. 19 indexed citations
10.
Chen, Yuh-Min, Chun-Ming Tsai, Shih-Hao Liu, et al.. (2011). A Phase II Randomized Trial of Gefitinib Alone or with Tegafur/Uracil Treatment in Patients with Pulmonary Adenocarcinoma Who had Failed Previous Chemotherapy. Journal of Thoracic Oncology. 6(6). 1110–1116. 23 indexed citations
11.
Chen, Yuh‐Min, Jen-Fu Shih, Chun‐Ming Tsai, et al.. (2009). Revisiting Squamous Cell Carcinoma of the Lungs-A Disease Given Less Attention. 25(6). 393–402. 1 indexed citations
12.
Chang, Gee‐Chen, Ko‐Jiunn Liu, Chia‐Ling Hsieh, et al.. (2006). Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes. Clinical Cancer Research. 12(19). 5746–5754. 128 indexed citations
13.
Chen, Yuh-Min, Jen-Fu Shih, Reury-Perng Perng, Chun-Ming Tsai, & Jacqueline Whang‐Peng. (2006). A Randomized Trial of Different Docetaxel Schedules in Non-small Cell Lung Cancer Patients Who Failed Previous Platinum-Based Chemotherapy. CHEST Journal. 129(4). 1031–1038. 80 indexed citations
14.
Shiah, Her-Shyong, Yee Chao, Li‐Tzong Chen, et al.. (2006). Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 58(5). 654–664. 10 indexed citations
15.
16.
Chen, Yuh‐Min, Chun‐Ming Tsai, Jacqueline Whang‐Peng, & Reury-Perng Perng. (2001). Interleukin-7 and Interleukin-12 Have Different Effects in Rescue of Depressed Cellular Immunity: Comparison of Malignant and Tuberculous Pleural Effusions. Journal of Interferon & Cytokine Research. 21(4). 249–256. 6 indexed citations
17.
Chen, Yi‐Jen, et al.. (1997). Frequent detection of aberrant RNA transcripts of theCDKN2 gene in human gastric adenocarcinoma. International Journal of Cancer. 71(3). 350–354. 19 indexed citations
18.
Caporaso, Neil E., Jean Whitehouse, Pablo Bertín, et al.. (1991). A 20 Year Clinical and Laboratory Study of Familial B-Chronic Lymphocytic Leukemia in a Single Kindred. Leukemia & lymphoma. 3(5-6). 331–342. 9 indexed citations
19.
Broder, Samuel, David G. Poplack, Jacqueline Whang‐Peng, et al.. (1978). Characterization of a Suppressor-Cell Leukemia. New England Journal of Medicine. 298(2). 66–72. 127 indexed citations
20.
Whang‐Peng, Jacqueline, et al.. (1973). The Transplacental Passage of Fetal Leukocytes into the Maternal Blood. Experimental Biology and Medicine. 142(1). 50–53. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Aglietta Breakdown of academic impact, for papers by James F. Holland Breakdown of academic impact, for papers by Joseph R. Bertino Breakdown of academic impact, for papers by Mitsune Tanimoto Breakdown of academic impact, for papers by Christian Peschel Breakdown of academic impact, for papers by Charles Dumontet Breakdown of academic impact, for papers by Joel S. Greenberger Breakdown of academic impact, for papers by Minna Tanner Breakdown of academic impact, for papers by Maurizio D’Incalci Breakdown of academic impact, for papers by Susan M. Blaney
Rankless by CCL
2026